BullsNBears.com, Inc. will offer a fair and open playing field with information for all interrelating members. BullsNBears.com, Inc. will provide full access equally to all its members while developing and ever-expanding database from all the financial community sectors. BullsNBears.com, Inc. will also provide members the opportunity to profile their companies and/or services and get connected with individuals/companies within the network which whom they share some common interest or synergies. Through the creation of profiles, Smart Data development will create opt-in options and laser precise targeting for distribution lists within the network membership.
Company Data
Industry: Financial Services
Contact: Nick Arroyo
Phone: 855.552.BNBI (2624)
Email: [email protected]
Address: BullsNBears.com, Inc.
4731 W. Atlantic Ave.
Suite 7
Delray Beach, FL 33445
Fiscal Year End: December, 31st
Executives: Nick Arroyo – President & CEO, James M. Palladino – Chairman, Secretary and Director
Online Resources
Company Website:
Stock Information:
Company Fillings
Guardian 8 Holdings, through its wholly owned subsidiary, Guardian 8 Corporation, develops and manufactures innovative personal security devices designed to deliver layered defense for low-impact de-escalation and risk mitigation. It’s initial product, the G8 ProV2 leverages a thoughtful collection of non-lethal technologies including a Laser Spotter, Alerting Siren, Camera, Strobe Light and O.C Spray to give security guards a single solution for effectively defending against aggressive subjects over 10 feet away. The unit’s inherent risk mitigation capabilities are further enhanced through use of a Bluetooth® driven Command Center Communication Link and Incident Recording Capabilities. The company focuses on marketing its personal defense solution to professional security organizations, as well as individuals and families. Guardian 8 Holdings is based in Scottsdale, Arizona.
Company Data
Industry: Security Industry
Contact: Steve Cochennet CEO
Phone: 913.317.8887
IR Email: [email protected]
Address: Guardian 8 Holdings
15230 N. 75th St.
Suite 1002
Scottsdale, AZ 85260
Fiscal Year End: December, 31st
Executives: Steve Cochennet CEO, Paul Hughes COO
Online Resources
Company Website:
Stock Information:
Company Fillings
Research Report
]]>
Omni Bio Pharmaceutical, Inc. (OTCBB: OMBP) is a clinical-stage biopharmaceutical company that has licensed potential new therapies currently in development for an existing FDA approved drug – Alpha-1 antitrypsin (AAT). Their strategy is to advance new therapies for AAT that we believe have the potential to move through clinical trials quickly, shepherd them through the FDA approval process and advance them through to commercialization. They intend to leverage clinical trials and sponsored research agreements with collaborations with existing AAT manufacturers for the development and commercialization of AAT in additional indications that potentially could exceed AAT’s current estimated market of $400 million. They plan to collaborate with companies that have the infrastructure, expertise and large scale marketing capability to properly handle late-stage clinical development and commercialization.Company Data
Industry: BioTech
IR Contact: Robert Ogden CFO
Phone: (720) 488-4754
IR Email: [email protected]
Address: OmniBio Pharmaceutical, Inc.
5350 S. Roslyn Street, Suite 430
Greenwood Village, CO 80111
Fiscal Year End: December, 31st
Executives: Bruce Schneider, PH.D CEO, Charles Dinarello CSO, Robert Ogden CFO
Online Resources
Company Website:
Stock Information:
Company Fillings
Video Presentations
Watch this video to learn more about Omni Bio’s breakthrough research for plasma and synthetic Alpha-1 Antitrypsin (AAT).
Dr. Charles Dinarello discusses article he co-authored in Blood Magazine
]]>
Native American Energy Group, Inc. operates as a development-stage energy resource development and management company. The company engages in the acquisition and management of Native American land and fee land acreage in Montana and Alaska; and the exploration for and development of oil and natural gas properties. It holds three principal projects, including the development of oil and gas interests in the Williston Basin in Montana; development of coal-bed methane natural gas in the Cook Inlet Basin in Alaska; and implementation of vertical-axis wind turbine power generation technology for the production of green energy in the United States, including Alaska and the U.S. Native American Indian reservations. The company is based in Forest Hills, New York.
Company Data
Industry: Energy
IR Contact: Richard Ross
Phone: (718) 408-2323
Address: Native American Energy Group, Inc.
1979 Marcus Avenue Suite 210
Lake Success, NY 11042
Fiscal Year End: December, 31st
Executives: Joseph G. D’Arrigo President and CEO, Raj S. Nanvaan Vice President and CFO, Richard Ross CCC and IR
Online Resources
Company Website:
Stock Information:
Company Fillings
Zacks Research Report
]]>
Retrophin, Inc. (OTCQB: RTRX) is a publicly-traded New York-based biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases.
Company Data
Industry: BioTech
IR Contact: Martin Shkreli CEO
IR Email: [email protected]
Phone: (212) 983-1310
Address: Retrophin, Inc.
777 Third Avenue, 22nd Floor
New York, NY 10017
Fiscal Year End: December, 31st
Executives: Martin Shkreli – President and CEO
Online Resources
Company Website:
Stock Information:
Company Fillings
Company Presentation
http://retrophin.com/retrophin/News/Retrophin%20Feb%2012%202013%20Presentation
]]>